logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hatim Husain

University of California System
H指数:32
被引数:7,410

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinical strategies for lung cancer management: Recommendations from the Bridging the Gaps Lung Cancer Consensus Conference 2024

肺癌管理临床策略：2024年弥合差距肺癌共识会议的建议

Cancer
IF5.1
2025-08-260
PRE
Narjust Florez MD; Sandip Patel MD; Heather A. Wakelee MD; Julia Rotow MD; Elaine Shum MD; Jacob Sands MD; Ravi Salgia MD, PhD; Fred R. Hirsch MD, PhD; Solange Peters MD, PhD; Joshua Sabari MD; Hatim Husain MD; Lyudmila Bazhenova MD; Erminia Massarelli MD, PhD, MS; Leah M. Backhus MD, MPH; Percy Lee MD; Roy S. Herbst MD, PhD; Christine Bestvina MD; Kristin Higgins MD; Aakash Desai MD, MPH; Martin Dietrich MD, PhD; Hari Balaji Keshava MD, MS; Balazs Halmos MD, MS; David R. Gandara MD; Jonathan Wesley Riess MD, MS; Ana I. Velázquez MD, MSc; Anjali Sibley MD, MPH; Misty Shields MD, PhD; Triparna Sen PhD, MS; Edward S. Kim MD, MBA
Osimertinib versus comparator first-generation epidermal growth factor receptor tyrosine kinase inhibitors as first-line treatment in patients with advanced EGFR-mutated non-small cell lung cancer: a Chinese, multicenter, real-world cohort study
TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2023-11-015
OAAI
Zhang, Dongming; Liu, Xiaoyan; Shen, Fangfang; Zhao, Dahai; Shi, Yuequan; Zhang, Haoran; Liu, Jia; Gao, Xiaoxing; Chen, Minjiang; Zhao, Jing; Zhong, Wei; Gao, Junzhen; He, Min; Liu, Yonggang; Yang, Xiaoling; Qin, Jianwen; Tang, Yuling; Mu, Xinlin; Gu, Yangchun; Zhang, Shucai; Chen, Xueqin; Pang, Li; Meng, Qingwei; Guo, Ye; Zhang, Yuhui; Li, Wei; Xing, Puyuan; Cheng, Yuan; Xin, Tao; Li, Qingxia; Li, Yu; Chen, Jun; Gao, Feng; Jin, Bo; Rossi, Antonio; Adachi, Hiroyuki; Guerrera, Francesco; Husain, Hatim; Xu, Yan; Wang, Mengzhao
Osimertinib in NSCLC With Atypical EGFR-Activating Mutations: A Retrospective Multicenter Study

奥希替尼治疗非典型EGFR激活突变的非小细胞肺癌: 一项回顾性多中心研究

JTO CLINICAL AND RESEARCH REPORTS
IF3.5
2023-03-0120
OA
Ji, Jingran; Aredo, Jacqueline, V; Piper-Vallillo, Andrew; Huppert, Laura; Rotow, Julia K.; Husain, Hatim; Stewart, Susan; Cobb, Rosemary; Wakelee, Heather A.; Blakely, Collin M.; Wong, Melisa L.; Gubens, Matthew A.; Madani, Mohammad H.; Digumarthy, Subba R.; Mccoach, Caroline; Piotrowska, Zofia; Neal, Joel W.; Riess, Jonathan W.
A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer

PF-06747775单药或联合帕博西尼治疗表皮生长因子受体突变型晚期非小细胞肺癌的1b/2期研究

EXPERT OPINION ON INVESTIGATIONAL DRUGS
IF4.1
2022-06-036
OA
Cho, Byoung Chul; Goldberg, Sarah B.; Kim, Dong-Wan; Socinski, Mark A.; Burns, Timothy F.; Lwin, Zarnie; Pathan, Nuzhat; Ma, Wei Dong; Masters, Joanna C.; Cossons, Nandini; Wilner, Keith; Nishio, Makoto; Husain, Hatim
The efficacy of anlotinib as third-line treatment for non-small cell lung cancer by EGFR mutation status: a subgroup analysis of the ALTER0303 randomized phase 3 study

通过EGFR突变状态评估安洛替尼作为非小细胞肺癌三线治疗的疗效: ALTER0303随机3期研究的亚组分析

TRANSLATIONAL LUNG CANCER RESEARCH
IF3.5
2022-05-017
OAAI
Zhao, Yizhuo; Wang, Qiming; Zhang, Li; Shi, Jianhua; Wang, Zhehai; Cheng, Ying; He, Jianxing; Shi, Yuankai; Chen, Weiqiang; Luo, Yi; Wu, Lin; Wang, Xiuwen; Nan, Kejun; Jin, Faguang; Dong, Jian; Li, Baolan; Yamaguchi, Fumihiro; Breadner, Daniel; Nagano, Tatsuya; Tanaka, Fumihiro; Husain, Hatim; Li, Kai; Han, Baohui

研究方向

暂未获取到该数据
B
Brian Woodward
H 指数:25论文数:119被引数:5,843
V
Victor E. Velculescu
H 指数:128论文数:857被引数:11.9万
J
Jillian Phallen
H 指数:28论文数:204被引数:9,086
A
Alessandro Leal
H 指数:15论文数:199被引数:4,189
R
Razelle Kurzrock
H 指数:144论文数:2,330被引数:8.7万
L
Luis A. Díaz
H 指数:124论文数:980被引数:11.3万
V
Valsamo Anagnostou
H 指数:55论文数:571被引数:1.8万
J
Julia Rotow
H 指数:23论文数:216被引数:3,934
K
Kevin Lu
H 指数:5论文数:44被引数:202
S
Scott M. Lippman
H 指数:114论文数:1,127被引数:6.3万